1. Home
  2. BCAB
  3. BCAB News

Latest BioAtla Inc. (BCAB) News on September 17, 2025

BioAtla Presents Phase 2 Ozuriftamab Vedotin (Oz-V) Clinical Trial Data Demonstrating Compelling Antitumor Activity in HPV-Associated Oropharyngeal Squamous Cell Carcinoma (HPV+ OPSCC) at the 1.8 mg/kg Q2W dosing regimen
BCAB

GlobeNewswire

3 months ago

BioAtla Presents Phase 2 Ozuriftamab Vedotin (Oz-V) Clinical Trial Data Demonstrating Compelling Antitumor Activity in HPV-Associated Oropharyngeal Squamous Cell Carcinoma (HPV+ OPSCC) at the 1.8 mg/kg Q2W dosing regimen

BCAB

GuruFocus.com

4 months ago

BioAtla Inc (BCAB) Q1 2025 Earnings Call Highlights: Promising Clinical Progress Amid Financial ...

BioAtla Reports First Quarter 2025 Financial Results and Highlights Recent Progress
BCAB

GlobeNewswire

4 months ago

BioAtla Reports First Quarter 2025 Financial Results and Highlights Recent Progress

BioAtla to Participate in the Citizens Life Sciences Conference
BCAB

GlobeNewswire

5 months ago

BioAtla to Participate in the Citizens Life Sciences Conference

BioAtla to Announce First Quarter 2025 Financial Results and Provide Business Highlights on May 6, 2025
BCAB

GlobeNewswire

5 months ago

BioAtla to Announce First Quarter 2025 Financial Results and Provide Business Highlights on May 6, 2025

BioAtla Announces Poster Presentations at the 2025 American Association for Cancer Research (AACR) Annual Meeting
BCAB

GlobeNewswire

5 months ago

BioAtla Announces Poster Presentations at the 2025 American Association for Cancer Research (AACR) Annual Meeting

BioAtla Announces Upcoming Poster Presentation at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
BCAB

GlobeNewswire

5 months ago

BioAtla Announces Upcoming Poster Presentation at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting

Companies Like BioAtla (NASDAQ:BCAB) Could Be Quite Risky
BCAB

Simply Wall St.

6 months ago

Companies Like BioAtla (NASDAQ:BCAB) Could Be Quite Risky

BCAB

Thomson Reuters StreetEvents

6 months ago

Q4 2024 Bioatla Inc Earnings Call

BCAB

GuruFocus.com

6 months ago

BioAtla Inc (BCAB) Q4 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges

BioAtla Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Progress
BCAB

GlobeNewswire

6 months ago

BioAtla Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Progress

BioAtla Announces Two Poster Presentations at Upcoming Medical Meetings
BCAB

GlobeNewswire

6 months ago

BioAtla Announces Two Poster Presentations at Upcoming Medical Meetings

BioAtla to Announce Fourth Quarter and Full-Year 2024 Financial Results and Provide Business Highlights on March 27, 2025
BCAB

GlobeNewswire

6 months ago

BioAtla to Announce Fourth Quarter and Full-Year 2024 Financial Results and Provide Business Highlights on March 27, 2025

BioAtla (BCAB) Upgraded to Buy: Here's What You Should Know
BCAB

Zacks

8 months ago

BioAtla (BCAB) Upgraded to Buy: Here's What You Should Know

BCAB

MT Newswires

9 months ago

BioAtla Prices Registered Direct Offering of 9.7 Million Shares for Expected Gross Proceeds of $9.2 Million

BioAtla, Inc. Announces Registered Direct Offering to Advance Two Mid-Stage Clinical Programs to Key Inflection Points
BCAB

GlobeNewswire

9 months ago

BioAtla, Inc. Announces Registered Direct Offering to Advance Two Mid-Stage Clinical Programs to Key Inflection Points

Insiders Give Up US$66k As BioAtla Stock Drops To US$1.31
BCAB

Simply Wall St.

9 months ago

Insiders Give Up US$66k As BioAtla Stock Drops To US$1.31

BioAtla Presented Data Characterizing Mutated KRAS Genotype and Clinical Outcomes in Patients with Advanced NSCLC Treated with Mecbotamab Vedotin (Mec-V), a CAB-AXL-ADC, at the IASLC 2024 Hot Topic in Basic & Translational Science Meeting
BCAB

GlobeNewswire

9 months ago

BioAtla Presented Data Characterizing Mutated KRAS Genotype and Clinical Outcomes in Patients with Advanced NSCLC Treated with Mecbotamab Vedotin (Mec-V), a CAB-AXL-ADC, at the IASLC 2024 Hot Topic in Basic & Translational Science Meeting

BioAtla Announces Upcoming Poster Presentation at the IASLC 2024 Hot Topic in Basic & Translational Science Meeting
BCAB

GlobeNewswire

9 months ago

BioAtla Announces Upcoming Poster Presentation at the IASLC 2024 Hot Topic in Basic & Translational Science Meeting

BCAB

MT Newswires

10 months ago

HC Wainwright Downgrades BioAtla to Neutral From Buy

BCAB

GuruFocus.com

10 months ago

BioAtla Inc (BCAB) Q3 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges

3 Promising US Penny Stocks With At Least $90M Market Cap
BCAB

Simply Wall St.

10 months ago

3 Promising US Penny Stocks With At Least $90M Market Cap

BioAtla Reports Third Quarter 2024 Financial Results and Highlights Recent Progress
BCAB

GlobeNewswire

10 months ago

BioAtla Reports Third Quarter 2024 Financial Results and Highlights Recent Progress

BioAtla to Announce Third Quarter 2024 Financial Results and Provide Business Highlights on November 7, 2024
BCAB

GlobeNewswire

a year ago

BioAtla to Announce Third Quarter 2024 Financial Results and Provide Business Highlights on November 7, 2024

BioAtla, Inc. (NASDAQ:BCAB) has caught the attention of institutional investors who hold a sizeable 39% stake
BCAB

Simply Wall St.

a year ago

BioAtla, Inc. (NASDAQ:BCAB) has caught the attention of institutional investors who hold a sizeable 39% stake

BioAtla, Inc. (BCAB): Among Michael Burry’s Top 10 Stock Picks Heading Into 2025
BCAB

Insider Monkey

a year ago

BioAtla, Inc. (BCAB): Among Michael Burry’s Top 10 Stock Picks Heading Into 2025

BCAB

GuruFocus.com

a year ago

BioAtla Inc (BCAB) Q2 2024 Earnings Call Highlights: Strategic Progress Amid Financial Challenges

BioAtla Announces Upcoming Poster Presentation at the 39th Society for Immunotherapy of Cancer Annual Meeting
BCAB

GlobeNewswire

a year ago

BioAtla Announces Upcoming Poster Presentation at the 39th Society for Immunotherapy of Cancer Annual Meeting

BioAtla Announces Upcoming Oral Presentation at the Society for Melanoma Research 21st International Congress
BCAB

GlobeNewswire

a year ago

BioAtla Announces Upcoming Oral Presentation at the Society for Melanoma Research 21st International Congress

BCAB

MT Newswires

a year ago

BioAtla, Context Therapeutics Enter Into License Agreement for BA3362 Cancer Treatment

BioAtla and Context Therapeutics Announce Exclusive Worldwide License Agreement to Develop and Commercialize BA3362, a Nectin-4 x CD3 T Cell Engaging Antibody
BCAB

GlobeNewswire

a year ago

BioAtla and Context Therapeutics Announce Exclusive Worldwide License Agreement to Develop and Commercialize BA3362, a Nectin-4 x CD3 T Cell Engaging Antibody

BioAtla and Context Therapeutics Announce Exclusive Worldwide License Agreement to Develop and Commercialize BA3362, a Nectin-4 x CD3 T Cell Engaging Antibody
BCAB

GlobeNewswire

a year ago

BioAtla and Context Therapeutics Announce Exclusive Worldwide License Agreement to Develop and Commercialize BA3362, a Nectin-4 x CD3 T Cell Engaging Antibody

BioAtla Presented Phase 2 Ozuriftamab Vedotin Clinical Trial Data Demonstrating Meaningful Antitumor Activity with Manageable Tolerability among Heavily Pretreated Patients with Squamous Cell Carcinoma of the Head and Neck (SCCHN) at the 2024 European Society for Medical Oncology (ESMO) Annual Meeting
BCAB

GlobeNewswire

a year ago

BioAtla Presented Phase 2 Ozuriftamab Vedotin Clinical Trial Data Demonstrating Meaningful Antitumor Activity with Manageable Tolerability among Heavily Pretreated Patients with Squamous Cell Carcinoma of the Head and Neck (SCCHN) at the 2024 European Society for Medical Oncology (ESMO) Annual Meeting

BioAtla Announces Upcoming Poster Presentation at the 2024 European Society for Medical Oncology (ESMO) Annual Meeting
BCAB

GlobeNewswire

a year ago

BioAtla Announces Upcoming Poster Presentation at the 2024 European Society for Medical Oncology (ESMO) Annual Meeting

Companies Like BioAtla (NASDAQ:BCAB) Could Be Quite Risky
BCAB

Simply Wall St.

a year ago

Companies Like BioAtla (NASDAQ:BCAB) Could Be Quite Risky

BioAtla to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
BCAB

GlobeNewswire

a year ago

BioAtla to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

Bioatla Reports Second Quarter 2024 Financial Results and Highlights Recent Progress
BCAB

GlobeNewswire

a year ago

Bioatla Reports Second Quarter 2024 Financial Results and Highlights Recent Progress

BioAtla to Announce Second Quarter 2024 Financial Results and Provide Business Highlights on August 8, 2024
BCAB

GlobeNewswire

a year ago

BioAtla to Announce Second Quarter 2024 Financial Results and Provide Business Highlights on August 8, 2024

These 2 “Strong Buy” Penny Stocks Are Poised for a Big Rally, Say Analysts
BCAB

TipRanks

a year ago

These 2 “Strong Buy” Penny Stocks Are Poised for a Big Rally, Say Analysts

BioAtla Highlighted Clinical Program and Pipeline Updates at Virtual R&D Day
BCAB

GlobeNewswire

a year ago

BioAtla Highlighted Clinical Program and Pipeline Updates at Virtual R&D Day

BioAtla receives FDA fast track designation for ozuriftamab vedotin
BCAB

Pharmaceutical Technology

a year ago

BioAtla receives FDA fast track designation for ozuriftamab vedotin

BCAB

MT Newswires

a year ago

BioAtla's Ozuriftamab Vedotin Receives FDA Fast-Track Designation; Shares Rise

BioAtla Granted FDA Fast Track Designation for Ozuriftamab Vedotin (CAB-ROR2-ADC) for Treatment of Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
BCAB

GlobeNewswire

a year ago

BioAtla Granted FDA Fast Track Designation for Ozuriftamab Vedotin (CAB-ROR2-ADC) for Treatment of Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Insider Traders Lose US$67k As BioAtla Drops
BCAB

Simply Wall St.

a year ago

Insider Traders Lose US$67k As BioAtla Drops

BioAtla to Host Virtual R&D Day on Clinical Program and Pipeline Updates on July 25, 2024
BCAB

GlobeNewswire

a year ago

BioAtla to Host Virtual R&D Day on Clinical Program and Pipeline Updates on July 25, 2024

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers
BCAB

GOBankingRates

a year ago

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers

Bumrah delivers as India beat Pakistan in low-scoring thriller
BCAB

AFP

a year ago

Bumrah delivers as India beat Pakistan in low-scoring thriller

Italy beat Bosnia in final Euros warm-up
BCAB

AFP

a year ago

Italy beat Bosnia in final Euros warm-up

Macron Calls French Legislative Election After Far-Right Surge
BCAB

Bloomberg

a year ago

Macron Calls French Legislative Election After Far-Right Surge

Trump loyalists proud to support 'felon' at Las Vegas rally
BCAB

AFP

a year ago

Trump loyalists proud to support 'felon' at Las Vegas rally

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia
BCAB

Business Insider

a year ago

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

The Best Woody Perfume For Women
BCAB

Insider Monkey

a year ago

The Best Woody Perfume For Women

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase
BCAB

Reuters

a year ago

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

BioAtla to Participate in the Jefferies Global Healthcare Conference
BCAB

GlobeNewswire

a year ago

BioAtla to Participate in the Jefferies Global Healthcare Conference

BioAtla Presenting Phase 1 Evalstotug Clinical Trial Data Demonstrating Clinical Benefit at the Upcoming 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
BCAB

GlobeNewswire

a year ago

BioAtla Presenting Phase 1 Evalstotug Clinical Trial Data Demonstrating Clinical Benefit at the Upcoming 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

Institutional owners may consider drastic measures as BioAtla, Inc.'s (NASDAQ:BCAB) recent US$35m drop adds to long-term losses
BCAB

Simply Wall St.

a year ago

Institutional owners may consider drastic measures as BioAtla, Inc.'s (NASDAQ:BCAB) recent US$35m drop adds to long-term losses

BCAB

GuruFocus.com

a year ago

BioAtla Inc (BCAB) (Q1 2024) Earnings Call Transcript Highlights: Strategic Adjustments and ...

BioAtla Reports First Quarter 2024 Financial Results and Highlights Recent Progress
BCAB

GlobeNewswire

a year ago

BioAtla Reports First Quarter 2024 Financial Results and Highlights Recent Progress

BioAtla to Participate in the Citizens JMP Life Sciences Conference
BCAB

GlobeNewswire

a year ago

BioAtla to Participate in the Citizens JMP Life Sciences Conference

BioAtla to Announce First Quarter 2024 Financial Results and Provide Business Highlights on May 14, 2024
BCAB

GlobeNewswire

a year ago

BioAtla to Announce First Quarter 2024 Financial Results and Provide Business Highlights on May 14, 2024

BCAB

MT Newswires

a year ago

BioAtla's Multiple Cancer Drug Candidate Receives FDA Clearance

BioAtla Announces FDA Clearance of Investigational New Drug Application for BA3361, a CAB-Nectin-4 Antibody Drug Conjugate for the Treatment of Multiple Tumors
BCAB

GlobeNewswire

a year ago

BioAtla Announces FDA Clearance of Investigational New Drug Application for BA3361, a CAB-Nectin-4 Antibody Drug Conjugate for the Treatment of Multiple Tumors

BioAtla Announces Upcoming Poster Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
BCAB

GlobeNewswire

a year ago

BioAtla Announces Upcoming Poster Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

We Think BioAtla (NASDAQ:BCAB) Needs To Drive Business Growth Carefully
BCAB

Simply Wall St.

a year ago

We Think BioAtla (NASDAQ:BCAB) Needs To Drive Business Growth Carefully

BioAtla, Inc. (NASDAQ:BCAB) Q4 2023 Earnings Call Transcript
BCAB

Insider Monkey

a year ago

BioAtla, Inc. (NASDAQ:BCAB) Q4 2023 Earnings Call Transcript

BCAB

Thomson Reuters StreetEvents

a year ago

Q4 2023 Bioatla Inc Earnings Call

BCAB

GuruFocus.com

a year ago

BioAtla Inc (BCAB) Posts Q4 and Full Year 2023 Financial Results

BioAtla Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Progress
BCAB

GlobeNewswire

a year ago

BioAtla Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Progress

BioAtla to Announce Fourth Quarter and Full-Year 2023 Financial Results and Provide Business Highlights on March 26, 2024
BCAB

GlobeNewswire

a year ago

BioAtla to Announce Fourth Quarter and Full-Year 2023 Financial Results and Provide Business Highlights on March 26, 2024

BioAtla Announces Poster Presentations at the 2024 American Association for Cancer Research (AACR) Annual Meeting
BCAB

GlobeNewswire

2 years ago

BioAtla Announces Poster Presentations at the 2024 American Association for Cancer Research (AACR) Annual Meeting

Do CB Financial Services' (NASDAQ:CBFV) Earnings Warrant Your Attention?
BCAB

Simply Wall St.

2 years ago

Do CB Financial Services' (NASDAQ:CBFV) Earnings Warrant Your Attention?

First National Corporation Reports Annual and Fourth Quarter 2023 Financial Results
BCAB

GlobeNewswire

2 years ago

First National Corporation Reports Annual and Fourth Quarter 2023 Financial Results

Dave's Repurchase of FTX Convertible Note for $71 Million Finalized
BCAB

PR Newswire

2 years ago

Dave's Repurchase of FTX Convertible Note for $71 Million Finalized

INmune Bio Announces FDA Removal of Clinical Hold for Alzheimer’s Disease Program
BCAB

GlobeNewswire

2 years ago

INmune Bio Announces FDA Removal of Clinical Hold for Alzheimer’s Disease Program

Allspring Closed-End Funds Declare Monthly Distributions
BCAB

PR Newswire

2 years ago

Allspring Closed-End Funds Declare Monthly Distributions

Concord Acquisition Corp III Receives Noncompliance Notification from the New York Stock Exchange Regarding Minimum Public Stockholders
BCAB

PR Newswire

2 years ago

Concord Acquisition Corp III Receives Noncompliance Notification from the New York Stock Exchange Regarding Minimum Public Stockholders

Bit Digital, Inc. Announces Commencement of Revenue Generation for Inaugural AI Contract
BCAB

PR Newswire

2 years ago

Bit Digital, Inc. Announces Commencement of Revenue Generation for Inaugural AI Contract

Anixa Biosciences Announces Japanese Patent on Ovarian Cancer Vaccine Technology
BCAB

PR Newswire

2 years ago

Anixa Biosciences Announces Japanese Patent on Ovarian Cancer Vaccine Technology

EGain (EGAN) Rises Higher Than Market: Key Facts
BCAB

Zacks

2 years ago

EGain (EGAN) Rises Higher Than Market: Key Facts

Manhattan Vintage Announces Partnership With The RealReal for Its NYC Winter Show, Feb. 2-4, 2024
BCAB

PR Newswire

2 years ago

Manhattan Vintage Announces Partnership With The RealReal for Its NYC Winter Show, Feb. 2-4, 2024

WhiteHorse Finance, Inc. Mourns the Passing of Director Kevin Burke
BCAB

PR Newswire

2 years ago

WhiteHorse Finance, Inc. Mourns the Passing of Director Kevin Burke

Amprius Broadens Product Portfolio with New Commercially Available Silicon Anode Battery Platform – SiCoreTM
BCAB

Business Wire

2 years ago

Amprius Broadens Product Portfolio with New Commercially Available Silicon Anode Battery Platform – SiCoreTM

4 Solid Profitable Stocks to Buy Using Net Income Ratio
BCAB

Zacks

2 years ago

4 Solid Profitable Stocks to Buy Using Net Income Ratio

Shareholders May Be More Conservative With Northern Technologies International Corporation's (NASDAQ:NTIC) CEO Compensation For Now
BCAB

Simply Wall St.

2 years ago

Shareholders May Be More Conservative With Northern Technologies International Corporation's (NASDAQ:NTIC) CEO Compensation For Now

Q3 Earnings Roundup: ON24 (NYSE:ONTF) And The Rest Of The Sales And Marketing Software Segment
BCAB

StockStory

2 years ago

Q3 Earnings Roundup: ON24 (NYSE:ONTF) And The Rest Of The Sales And Marketing Software Segment

TenX Keane Acquisition Announces Contribution to Trust Account in Connection with Extension Amendment Proposal
BCAB

GlobeNewswire

2 years ago

TenX Keane Acquisition Announces Contribution to Trust Account in Connection with Extension Amendment Proposal

Ken Langone Just Invested $3 Million in This Struggling Green Stock
BCAB

Barrons.com

2 years ago

Ken Langone Just Invested $3 Million in This Struggling Green Stock

Amundi US Declares Monthly Distributions for Pioneer Closed-End Funds
BCAB

Business Wire

2 years ago

Amundi US Declares Monthly Distributions for Pioneer Closed-End Funds

Frequency Electronics, Inc. (NASDAQ:FEIM) is definitely on the radar of institutional investors who own 38% of the company
BCAB

Simply Wall St.

2 years ago

Frequency Electronics, Inc. (NASDAQ:FEIM) is definitely on the radar of institutional investors who own 38% of the company

The 3 Hottest Quantum Computing Stocks to Watch in 2024
BCAB

InvestorPlace

2 years ago

The 3 Hottest Quantum Computing Stocks to Watch in 2024

Maiden Holdings Ltd Director Yehuda Neuberger Sells 277,000 Shares
BCAB

GuruFocus.com

2 years ago

Maiden Holdings Ltd Director Yehuda Neuberger Sells 277,000 Shares

Here's Why You Should Bet on Rigel Pharmaceuticals (RIGL) Now
BCAB

Zacks

2 years ago

Here's Why You Should Bet on Rigel Pharmaceuticals (RIGL) Now

Are Investors Undervaluing Viemed Healthcare, Inc. (NASDAQ:VMD) By 46%?
BCAB

Simply Wall St.

2 years ago

Are Investors Undervaluing Viemed Healthcare, Inc. (NASDAQ:VMD) By 46%?

Co-Founder of BioAtla Jay Short Buys 2.3% More Shares
BCAB

Simply Wall St.

2 years ago

Co-Founder of BioAtla Jay Short Buys 2.3% More Shares

7 Micro-Cap Stocks for Risk-Tolerant Investors to Buy in 2024
BCAB

InvestorPlace

2 years ago

7 Micro-Cap Stocks for Risk-Tolerant Investors to Buy in 2024

Rimini Street is Recognized with Great Place to Work® Certifications in Singapore and Japan, and Ranked Top 50 of India’s Best Workplaces™ in IT & IT-BPM Category
BCAB

Business Wire

2 years ago

Rimini Street is Recognized with Great Place to Work® Certifications in Singapore and Japan, and Ranked Top 50 of India’s Best Workplaces™ in IT & IT-BPM Category

BioAtla to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
BCAB

GlobeNewswire

2 years ago

BioAtla to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

15 Best Falling Stocks To Buy Now
BCAB

Insider Monkey

2 years ago

15 Best Falling Stocks To Buy Now

Amundi US Declares Monthly Distributions for Pioneer Closed-End Funds
BCAB

Business Wire

2 years ago

Amundi US Declares Monthly Distributions for Pioneer Closed-End Funds

After losing 78% in the past year, BioAtla, Inc. (NASDAQ:BCAB) institutional owners must be relieved by the recent gain
BCAB

Simply Wall St.

2 years ago

After losing 78% in the past year, BioAtla, Inc. (NASDAQ:BCAB) institutional owners must be relieved by the recent gain

Share on Social Networks: